Secondary |
Product Used For Unknown Indication |
48.6% |
Depression |
7.2% |
Bipolar I Disorder |
4.8% |
Insomnia |
4.4% |
Epilepsy |
4.1% |
Anxiety |
3.7% |
Abnormal Behaviour |
3.5% |
Intentional Overdose |
3.5% |
Schizophrenia |
3.1% |
Schizophrenia, Paranoid Type |
3.1% |
Ill-defined Disorder |
2.6% |
Psychotic Disorder |
2.0% |
Ankylosing Spondylitis |
1.7% |
Toxicity To Various Agents |
1.5% |
Childhood Psychosis |
1.3% |
Dementia Alzheimer's Type |
1.3% |
Diabetes Mellitus |
1.1% |
Arrhythmia |
0.9% |
Hypertension |
0.9% |
Sleep Disorder |
0.9% |
|
Electrocardiogram Qt Prolonged |
18.8% |
Abnormal Behaviour |
7.2% |
Bradycardia |
7.2% |
Somnolence |
5.8% |
Sudden Death |
5.8% |
Vomiting |
5.8% |
Aggression |
4.3% |
Altered State Of Consciousness |
4.3% |
Death |
4.3% |
Extrapyramidal Disorder |
4.3% |
Hiccups |
4.3% |
Pulmonary Embolism |
4.3% |
Bundle Branch Block Right |
2.9% |
Cardiac Arrest |
2.9% |
Colitis Ischaemic |
2.9% |
Disorientation |
2.9% |
Hyperthermia |
2.9% |
Hyponatraemia |
2.9% |
Multiple Drug Overdose Intentional |
2.9% |
Spina Bifida |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
24.0% |
Depression |
12.1% |
Hiv Infection |
11.0% |
Myocardial Ischaemia |
7.6% |
Insomnia |
5.7% |
Bipolar I Disorder |
4.0% |
Type 2 Diabetes Mellitus |
3.6% |
Anxiety |
3.4% |
Intentional Overdose |
3.4% |
Schizophrenia |
3.2% |
Pain |
3.0% |
Agitation |
2.5% |
Hepatitis C |
2.3% |
Psychotic Disorder |
2.3% |
Bipolar Disorder |
2.1% |
Hypercholesterolaemia |
2.1% |
Bronchopneumonia |
1.9% |
Dementia Alzheimer's Type |
1.9% |
Sleep Disorder |
1.9% |
Diarrhoea |
1.7% |
|
Neutropenia |
13.2% |
Suicide Attempt |
11.8% |
Hypoglycaemia |
10.3% |
Renal Failure Acute |
5.9% |
Abnormal Behaviour |
4.4% |
Colitis Ischaemic |
4.4% |
Death |
4.4% |
Decreased Appetite |
4.4% |
Extrapyramidal Disorder |
4.4% |
Rhabdomyolysis |
4.4% |
Serotonin Syndrome |
4.4% |
Thrombocytopenic Purpura |
4.4% |
Agranulocytosis |
2.9% |
Anaemia |
2.9% |
Anaphylactic Shock |
2.9% |
Anxiety |
2.9% |
Atrial Flutter |
2.9% |
Back Pain |
2.9% |
Cholecystitis |
2.9% |
Confusional State |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
56.9% |
Pain |
13.8% |
Insomnia |
12.3% |
Anxiety |
9.2% |
Bipolar Ii Disorder |
6.2% |
Nausea |
1.5% |
|
Drug Interaction |
28.6% |
Hip Fracture |
19.0% |
Insomnia |
9.5% |
Logorrhoea |
9.5% |
Rhabdomyolysis |
9.5% |
Anosognosia |
4.8% |
Bipolar Disorder |
4.8% |
Disorientation |
4.8% |
Femoral Neck Fracture |
4.8% |
Hyperkalaemia |
4.8% |
|